Ligand validation:7COU

HTG: heptyl 1-thio-beta-D-glucopyranoside

HTG is a Ligand Of Interest in 7COU designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7COU_HTG_b_625	80%	41%	0.096	0.944	0.99	1.3	2	3	0	0	100%	1
7COU_HTG_B_625	69%	44%	0.112	0.927	1.04	1.11	2	1	0	0	100%	1
7COU_HTG_b_622	20%	36%	0.201	0.803	1.1	1.42	1	2	0	0	100%	1
7COU_HTG_B_622	19%	34%	0.224	0.815	1	1.59	1	5	0	0	100%	1
7COU_HTG_c_523	18%	37%	0.268	0.857	0.96	1.48	2	1	0	0	100%	1
7COU_HTG_C_523	16%	40%	0.308	0.877	0.92	1.41	1	1	0	0	100%	1
7COU_HTG_h_101	10%	21%	0.286	0.819	1.14	2.11	2	5	0	0	84%	0.8421
7COU_HTG_B_623	5%	33%	0.399	0.801	0.81	1.82	1	5	0	0	100%	1
7COU_HTG_D_411	3%	39%	0.302	0.645	1.06	1.33	2	1	0	0	84%	0.8421
7COU_HTG_V_202	2%	61%	0.442	0.812	0.21	1.25	-	2	0	0	58%	0.5789
7COU_HTG_b_623	0%	34%	0.52	0.536	1	1.59	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	40%	0.092	0.971	1.13	1.22	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	45%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.